UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


FORM 8-K


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): March 18, 2015

 


MGC Diagnostics Corporation

(Exact name of registrant as specified in its charter)

 

Minnesota

(State or other jurisdiction of incorporation)

 

001-13543 41-1579150
(Commission File Number) (IRS Employer Identification No.)
   
350 Oak Grove Parkway  
Saint Paul, Minnesota 55127-8599
(Address of principal executive offices) (Zip Code)

 

(651) 484-4874

(Registrant’s telephone number, including area code)


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 
 

 

Section 5 – Corporate Governance and Management

Item 5.07      Submission of Matters to a Vote of Security Holders

On March 18, 2015, MGC Diagnostics Corporation (the “Company”) held its 2015 Annual Meeting of Shareholders (the “Annual Meeting”). Of the 4,270,373 shares of the Company’s common stock outstanding and eligible to vote at the Annual Meeting, 3,199,238 shares were present either in person or by proxy.

The following describes the matters considered by the Company’s shareholders at the Annual Meeting and the results of the votes cast at the meeting:

 

Proposal 1.      To elect six directors of the Company to hold office until the next Annual Meeting of Shareholders or until their respective successors have been elected and qualified.

 

Nominee For Withhold Broker Non-Vote
Mark W. Sheffert 1,266,110 224,324 1,708,804
John R. Baudhuin 1,307,613 182,821 1,708,804
Terrence W. Bunge 1,317,382 173,052 1,708,804
Wendy D. Lynch, Ph.D. 1,252,110 238,324 1,708,804
Robert E. Munzenrider 1,252,110 238,324 1,708,804
Hendrik Struik 1,306,633 183,801 1,708,804

 

Proposal 2.       To ratify the appointment of Baker Tilly Virchow Krause, LLP as the independent registered public accounting firm for the Company for the fiscal year ending October 31, 2015.

 

For Against Abstain  
2,965,221 105,782 128,235  

 

Proposal 3.      To approve the Company’s executive compensation.

 

For Against Abstain Broker Non-Vote
1,313,190 131,547 45,697 1,708,804

 

Proposal 4.      To approve amendments to the Company’s 2007 Stock Incentive Plan.

 

For Against Abstain Broker Non-Vote
1,311,717 171,142 7,575 1,708,804

 

As a result, the shareholders elected each nominee as a director of the Company, ratified the appointment of Baker Tilly Virchow Krause, LLP as independent registered public accounting firm for the Company for the year ending October 31, 2015, approved the Company’s executive compensation and approved amendments to the Company’s 2007 Stock Incentive Plan.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MGC DIAGNOSTICS CORPORATION  
       
       
Dated:  March 19, 2015 By:  /s/ Wesley W. Winnekins  
    Wesley W. Winnekins  
    Chief Financial Officer